Human serum-resistant retroviral vector particles from galactosyl (α1-3) galactosyl containing nonprimate cell lines

Gene Therapy

Volumn 6, Issue 8, 1999, Pages 1397-1405

  Mason, J M ^a   Guzowski, D E ^a   Goodwin, L O ^a   Porti, D ^a   Cronin, K C ^a   Teichberg, S ^a   Pergolizzi, R G ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Gal; Gene therapy; Packaging cells; Retrovirus

Indexed keywords

GALACTOSE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL KILLING; CELL LINE; CONTROLLED STUDY; FERRET; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SERUM; VIRUS REPLICATION;

ANIMALS; BLOOD; BLOTTING, SOUTHERN; CELL LINE; CELL SURVIVAL; DISACCHARIDES; FERRETS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; RETROVIRIDAE;

EID: 0032840179     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300963     Document Type: Article

References (33)

1. Welsh RM, Cooper NR, Jensen FC, Oldstone MBA. Human serum lyses RNA tumor viruses. Nature 1975; 257: 612-614.
2. Welsh RM. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J Immunol 1977; 118: 348-354.
3. Bartholomew RM, Esser AF, Muller-Eberhard HJ. Lysis of oncornaviruses by human serum. J Exp Med 1978; 147: 844-853.
4. Repik PM, Strizki JM, Galili U. Differential host-dependent expression of α-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. J Gen Virol 1994; 75: 1177-1181.
5. Rother RP et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J Exp Mod 1995; 182: 1345-1355.
6. Takeuchi Y et al. Sensitization of cells and retroviruses to human serum by α(1-3) galactosyltransferase. Nature 1996; 379: 85-88.
7. Takeuchi YM et al. Sensitization of rhabdo-, lenti-, and spuma-viruses to human serum by galactosyl (α1-3) galactosylation. J Virol 1997; 71: 6174-6178.
8. Takeuchi Y et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994; 68: 8001-8007.
9. Pensiero MN, Wysocki CA, Nader K, Kikuchi GE. Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Hum Gene Ther 1996; 7: 1095-1101.
10. Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
11. Cornetta K et al. Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther 1993; 4: 579-588.
12. O'Neill RR et al. Envelope and long terminal sequences of cloned infectious NZB xenotropic murine leukemia virus. J Virol 1985; 53: 100-106.
13. Khan AS. Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses. J Virol 1984; 50: 864-871.
14. Hoshino H, Tanaka H, Miwa M, Okada H. Human T-cell leukaemia virus is not lysed by human serum. Nature 1984; 310: 324-325.
15. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-990.
16. Loiler SA, DiFronzo NL, Holland CA. Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line. J Virol 1997; 71: 4825-4828.
17. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
18. Soumalainen M, Garoff H. Incorporation of homologous and heterologous proteins into the envelope of moloney murine leukemia virus. J Virol 1994; 68: 4879-4889.
19. Goochee CF et al. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Biotechnology 1991; 9: 1347-1355.
20. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG. J Exp Med 1985; 162: 573-582.
21. Davis JK, Cassell GH, Minion FC, Wise KS. Mycoplasma host-cell interactions resulting in chronic inflammation: acquisition of host antigens and other mechanisms. Isr J Med Sci 1981; 17: 633-636.
22. Schofield L. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite? WHO Bulletin OMS Suppl 1990; 68: 66-73.
23. Goldring OL, Clegg JA, Smithers SR, Terry RJ. Acquisition of human blood group antigens by Schistosoma mansoni. J Clin Exp Immunol 1976; 26: 181-187.
24. Wrightsman RA, Dawson BD, Fouts DL, Manning JE. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. J Immunol 1994; 153: 3148-3154.
25. Kaluza G, Rott R, Schwarz RT. Carbohydrate-induced conformational changes of Semiliki forest virus glycoproteins determine antigenicity. Virology 1980; 102: 286-299.
26. Skehel JJ et al. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 1984; 81: 1779-1783.
27. Olofsson S, Sjoblom I, Jeansson S. Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides. J Gen Virol 1990; 71: 889-895.
28. Benjouad A et al. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol 1992; 66: 2473-2483.
29. Andersen KB. A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J Virol 1994; 68: 3175-3182.
30. Kayman S et al. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein. J Virol 1991; 65: 5323-5332.
31. Goff SP, Traktman P, Baltimore D. Isolation and properties of moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol 1981; 38: 239-248.
32. Morgan RA et al. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol 1993; 67: 4712-4721.
33. Stirling JW. Immuno and affinity probes for electron microscopy: a review of labeling and preparation techniques. J Hist Cytochem 1990; 38: 145-157.